文献速递主动脉疾病

现成开窗支架治疗近肾腹主动脉瘤的五年结果

Five Year Results of Off the Shelf Fenestrated Endografts for Elective and Emergency Repair of Juxtarenal Abdominal Aortic Aneurysm.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2021-01-15

这项前瞻性单中心非随机非对照试验评估了COOK Zenith p-Branch现成开窗支架治疗近肾腹主动脉瘤的五年结局。结论认为该装置在选定人群中安全有效,长期结果可接受但劣于定制装置。

要点

  • p-Branch现成支架可用于近肾腹主动脉瘤的择期和急诊修复。
  • 五年靶血管通畅率94.0%,无动脉瘤相关死亡,但肾脏不良事件最常见。
  • 长期结果可接受但劣于定制开窗装置,靶血管并发症需进一步改进。

核心结论

  • COOK Zenith p-Branch现成开窗支架治疗近肾腹主动脉瘤在选定人群中安全有效,择期和急诊均可应用。
  • 长期结果可接受但劣于定制开窗装置,靶血管并发症较定制装置更常见。

研究设计与样本

  • 收集人口学、解剖、手术相关及五年随访数据,由核心实验室分析裁定;主要目标为五年无干预生存和总生存。

主要发现

  • 急诊病例从就诊到p-Branch植入平均时间28小时(范围0-122小时),择期病例平均67天(范围20-112天)。
  • 中位手术时间283分钟(范围161-475分钟),技术成功率91%。
  • 平均随访45个月(标准差±24.4个月),最常见不良事件为肾脏损伤。
  • 靶血管一期通畅率1年和5年分别为96.4%和94.0%。

临床怎么用

  • 对于不适合定制开窗装置或需急诊修复的近肾腹主动脉瘤患者,可考虑使用p-Branch现成开窗支架。
  • 需关注靶血管并发症,尤其是肾脏不良事件,并加强术后随访。

局限性

  • 长期结果劣于定制开窗装置,靶血管并发症更常见。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Fenestrated endovascular aneurysm repair (FEVAR) is a well established treatment for complex abdominal aortic aneurysms (AAAs). FEVAR with custom made devices (CMDs) has limitations in both the emergency and elective settings due to time consuming manufacture. "Off the shelf" (OTS) fenestrated stent grafts are a potential solution. The primary goal was to evaluate the five year outcome of the COOK Zenith p-Branch OTS device at a single centre. METHODS: Patients with juxtarenal AAA meeting the inclusion criteria for the COOK Zenith p-Branch device were enrolled in a prospective, non-randomised, non-comparative trial from July 2012 to September 2015. Demographic, anatomical, procedure related, and five year follow up data were collected, analysed, and adjudicated by a core laboratory. The primary aims were to assess intervention free survival and overall survival at five years. RESULTS: Twenty-three patients were treated and 21 completed follow up. Mean time to p-Branch implantation after patient presentation was 28 hours (range 0-122 hours) in emergency cases and 67 days (range 20-112 days) in elective cases. Median procedure time was 283 minutes (range 161-475 minutes) and technical success was 91%. Mean follow up was 45 months (standard deviation ± 24.4 months). The most common adverse events were renal injuries. Primary target vessel patency was 96.4% and 94.0% after one and five years respectively. Mean time to first re-intervention was 469 days (range 0-1 567 days). Survival during the follow up period was 76%, with no aneurysm related deaths. CONCLUSION: FEVAR with the COOK Zenith p-Branch device is safe and effective for juxtarenal AAA in a selected patient population, in both elective and emergency settings. Long term outcomes are acceptable although inferior to CMDs. Mid and long term outcomes emphasise the p-Branch as a possible endovascular treatment for juxtarenal aortic pathology where CMD is not an option. Further innovation to address target vessel complications is needed, as these seem more prevalent than after repair with CMDs.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Sveinsson M, Sonesson B, Dias N, et al. Five Year Results of Off the Shelf Fenestrated Endografts for Elective and Emergency Repair of Juxtarenal Abdominal Aortic Aneurysm. Eur J Vasc Endovasc Surg. 2021. PMID: 33455820. doi:10.1016/j.ejvs.2020.12.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。